Herold Advisors’s DermTech, Inc. Common Stock DMTK Stock Holding History

Herold Advisors’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$6K	–	682
2021 Q3	$6K	Buy	+200	New	+$7.03K	﹤0.01%	657

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Herold Advisors's DMTK Position: Q4 2021 in Review

Herold Advisors sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2021, closing a stake of 200 shares — an estimated $6K sold.

Herold Advisors first reported a position in DMTK in Q3 2021 and held it in 1 quarter. The position peaked at $6K in Q3 2021. 143 funds tracked by Wall St. Rank hold DMTK as of Q4 2021.

Herold Advisors reported no remaining DermTech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Herold Advisors sold 200 DermTech, Inc. Common Stock shares in Q4 2021, an estimated $6K.
Herold Advisors first reported a position in DermTech, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
Herold Advisors's DermTech, Inc. Common Stock position peaked at $6K in Q3 2021.
143 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2021.

Based on Herold Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.